BDBM50533061 CHEMBL4469592
SMILES C[C@H]1CC[C@@](O)(CNC(=O)c2cc(C3CCOC3)n3cccc(Cl)c23)CC1
InChI Key InChIKey=XXKLQKSQFMIASW-XBAKSLADSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 50533061
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair